BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Aug 7, 2026; 32(29): 119809
Published online Aug 7, 2026. doi: 10.3748/wjg.119809
Figure 1
Figure 1 Comparison of progression-free survival and overall survival among the three groups. A: Progression-free survival; B: Overall survival. PSOX: Nab-paclitaxel plus oxaliplatin and S-1; SOX + XDL: Oxaliplatin plus S-1 combined with sintilimab; CAPOX: Capecitabine plus oxaliplatin.


Write to the Help Desk